Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome — Stella

Recruiting

Back to Netherton Syndrome trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Northwestern Memorial Hospital, Chicago, Illinois

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Quoin Pharmaceuticals

Enrollment target

~8 participants

Started

July 2025

Primary completion

July 2026

Age range

14 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov